Celltrion Pharm, Inc. (KOSDAQ:068760)
South Korea · Delayed Price · Currency is KRW 61,100
+600 (0.99%)
Nov 20, 2025, 3:30 PM KST
Celltrion Pharm Company Description
Celltrion Pharm, Inc., a pharmaceutical company, develops and sells biosimilars and over-the-counter drugs in South Korea.
The company offers hepatotonic, anti-inflammatory, antihistamine, respiratory apparatus, circulary system, digestive and stomachic, hormone/metabolic disease, antibiotic/antimycotic, nutrientia and tonic, immunology, oncology, and other drugs.
It serves university hospitals and general pharmacies. Celltrion Pharm Inc. was founded in 1976 and is based in Cheongju-si, South Korea.
Celltrion Pharm, Inc. (KOSDAQ:A068760) operates as a subsidiary of Celltrion, Inc.
Celltrion Pharm, Inc.
| Country | South Korea |
| Founded | 1976 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 328 |
| CEO | Yoo Young-Ho |
Contact Details
Address: 82, 2sandan-ro Cheongju-si South Korea | |
| Phone | 82 4 3717 7000 |
| Website | celltrionph.com |
Stock Details
| Ticker Symbol | 068760 |
| Exchange | KOSDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | KRW |
| ISIN Number | KR7068760008 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Yoo Young-Ho | Chief Executive Officer |